Skip to main content
    T

    Tharimmune Inc. (THAR)

    Official site

    BIOTECHNOLOGY

    $1.71
    -0.09 (-5.00%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Tharimmune Inc. (THAR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2025. Financial statements from company filings, amounts in US dollars.

    Tharimmune reported revenue of $0 for the fiscal year ended Dec 31, 2024. That year, net income was -$12.20M, operating cash flow was -$10.90M and free cash flow was -$10.90M. The quarter ended Sep 30, 2025 had revenue of $0 and net income of -$2.10M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2024, with an operating loss of $12.43M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss widened from the year before. In the quarter ended Sep 2025, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Research and development$6.39M$3.56M$2.28M$1.84M$847.27K$368.73K
    Operating income-$12.43M-$9.46M-$6.88M-$3.21M-$1.52M-$994.54K
    Net income-$12.20M-$9.32M-$8.47M-$2.21M-$2.42M-$1.53M
    EBITDA-$12.43M-$9.15M-$6.65M-$1.38MN/AN/A
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating income-$2.09M-$1.85M-$2.55M-$3.85M-$3.87M-$2.37M-$2.35M-$2.53M-$1.85M-$2.36M-$2.71M-$1.77M
    Net income-$2.10M-$1.86M-$2.54M-$3.82M-$3.80M-$2.33M-$2.26M-$2.47M-$1.82M-$2.34M-$2.69M-$1.77M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, cash and equivalents of $3.56M were 95.7% of total assets of $3.72M, against total liabilities of $2.41M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$3.72M$10.95M$6.69M$621.68K$294.80K$40.88K
    Current assets$3.72M$10.95M$6.69M$621.68K$294.80K$40.88K
    Cash and equivalents$3.56M$10.94M$6.51M$4.36K$191.85K$38.28K
    Total liabilities$2.41M$1.82M$1.14M$5.31M$4.01M$1.66M
    Short-term debtN/AN/AN/A$1.39M$563.42K$430.60K
    Long-term debtN/AN/AN/A$772.90K$1.29M$532.77K
    Shareholder equity$1.31M$9.13M$5.54M-$4.68M-$3.72M-$1.62M
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$7.70M$2.53M$1.66M$3.72M$5.25M$8.26M$8.89M$10.95M$3.17M$4.60M$4.72M$6.69M
    Total liabilities$1.54M$2.16M$2.48M$2.41M$2.23M$1.56M$1.84M$1.82M$1.41M$1.53M$1.52M$1.14M
    Cash and equivalents$7.61M$2.24M$1.08M$3.56M$4.77M$7.90M$8.43M$10.94M$2.69M$3.90M$3.57M$6.51M
    Shareholder equity$6.15M$367.36K-$814.67K$1.31M$3.02M$6.69M$7.05M$9.13M$1.76M$3.07M$3.20M$5.54M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$10.90M-$7.30M-$6.56M-$1.09M-$1.08M-$706.11K
    Capital expenditures$0$4$0$0$0$3
    Free cash flow-$10.90M-$7.30M-$6.56M-$1.09M-$1.08M-$706.12K
    Financing cash flow$3.53M$11.72M$13.06M$898.75K$1.23M$708.38K
    Fiscal years ended Dec 2019 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$1.86M-$1.14M-$2.69M-$3.03M-$2.86M-$2.18M-$2.83M-$1.42M-$908.97K-$1.51M-$3.46M-$1.06M
    Capital expenditures$1$0$1$0$3$3$1$0$0$3$0$0
    Free cash flow-$1.86M-$1.14M-$2.69M-$3.03M-$2.86M-$2.18M-$2.83M-$1.42M-$908.97K-$1.51M-$3.46M-$1.06M
    Last 12 quarters

    Frequently Asked Questions About THAR

    What is Tharimmune's annual revenue?

    Tharimmune reported revenue of $0 for the fiscal year ended Dec 31, 2024.

    Is Tharimmune profitable?

    No. Tharimmune reported net income of -$12.20M for the fiscal year ended Dec 31, 2024.

    How much free cash flow does THAR generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$10.90M minus capital expenditures of $0 produced free cash flow of -$10.90M.

    How much debt does Tharimmune have?

    The balance sheet dated Dec 31, 2024 reported cash and equivalents of $3.56M.